• UTP Solution (100 mM) for RNA Workflows

  2026-08-24

  UTP Solution is a high-purity, DNase- and RNase-free nucleotide stock for RNA synthesis workflows. The 100 mM Uridine-5'-triphosphate trisodium salt solution supports in vitro transcription, RNA amplification, siRNA synthesis, and biochemical studies of UTP-dependent metabolism.

• (-)-Blebbistatin for Cardiac Mechanobiology

  2026-08-23

  Pair reversible myosin II inhibition with transparent, stretchable microelectrode arrays to distinguish electrical activity from force generation in cardiac preparations. This workflow extends simultaneous electrophysiology and label-free metabolic imaging into controlled actin–myosin perturbation, while preserving spatial and temporal readouts.

• BMX-IN-1 Workflows for Kinase Research

  2026-08-22

  BMX-IN-1 is a selective, irreversible BMX kinase inhibitor for connecting target engagement with cancer-cell phenotypes and host-pathogen biology. This guide translates its covalent mechanism into practical dose-response, lysosomal-acidification, apoptosis, and cell-cycle workflows.

• Protease Inhibitor Cocktail for Plant Assays

  2026-08-22

  Discover how a Protease Inhibitor Cocktail can protect plant proteins during extraction without the confounding effects of EDTA. This evidence-aware guide connects plant cell protein stability with m6A-based plant-virus research and assay-specific workflow decisions.

• Annexin V-FITC/PI Apoptosis Assay Kit Guide

  2026-08-21

  The Annexin V-FITC/PI Apoptosis Assay Kit supports rapid discrimination of viable, early apoptotic, late apoptotic, and membrane-compromised cells using Annexin V-FITC and propidium iodide. It is intended for controlled research workflows in flow cytometry or fluorescence microscopy, not for diagnosis, medical decisions, or definitive assignment of a cell-death mechanism.

• Recombinant Human EGF: Mechanism and Workflow

  2026-08-20

  Epidermal Growth Factor is an EGFR-binding ligand that regulates cell proliferation and differentiation. Recombinant human EGF P1008 combines a defined His-tagged bacterial expression product with product-reported purity, endotoxin, storage, and BALB/c 3T3 activity benchmarks.

• BV6 IAP Antagonist: Assays and Workflows

  2026-08-20

  BV6 is a Smac mimetic for dissecting IAP-dependent survival, with practical applications in cancer-cell apoptosis, radiotherapy response, immune-cell cytotoxicity, and endometriosis treatment research. This workflow-centered guide connects dose selection and mechanism-resolved readouts with a 2025 study showing why reduced RIPK3 abundance should not be mistaken for blocked necroptosis.

• Perphenazine Workflows for D2 and Host-Directed Research

  2026-08-19

  Perphenazine is a dopamine D2 receptor antagonist that supports both receptor-signaling studies and phenothiazine-based host-defense assays. This workflow connects dose-controlled neuropharmacology experiments with ROS, autophagy, mitochondrial, and intracellular-bacteria readouts while emphasizing controls for cytotoxicity and receptor promiscuity.

• NSC-23766: From Rac1 Mechanism to Translation

  2026-08-19

  NSC-23766 is a Rac GTPase inhibitor that helps translational researchers connect Rac1-GEF biology with endothelial barrier disruption, apoptosis, cell-cycle phenotypes, and immune-cell cytoskeletal behavior. This thought-leadership perspective explains how to deploy NSC23766 trihydrochloride as a mechanistic probe while avoiding overinterpretation of context-dependent results.

• Metformin Hydrochloride in Immunometabolism

  2026-08-18

  Metformin Hydrochloride extends beyond conventional glucose studies as a controllable metabolic intervention for standardized whole-blood immune assays. This guide shows how to connect AMPK-linked metabolic changes with cytokine readouts, while controlling solubility, donor variability, vehicle effects, and assay timing.

• Podophyllotoxin: Mechanism, Evidence, and Workflows

  2026-08-18

  Podophyllotoxin is a microtubule-directed research compound used to investigate mitotic disruption, cell cycle arrest, and apoptosis. This guide separates evidence for native Podophyllotoxin from findings for the structurally modified derivative 5p and defines practical handling limits for N1790.

• QNZ (EVP4593): Reliable NF-κB Assays

  2026-08-17

  This scenario-based guide shows how QNZ (EVP4593), SKU A4217, can be integrated into NF-κB, viability, proliferation, and cytotoxicity workflows without confusing pathway inhibition with nonspecific cell injury. It covers assay design, solvent control, stock preparation, data interpretation, and practical vendor selection.

• Necrostatin-1: RIP1 Kinase Inhibitor Guide

  2026-08-17

  Necrostatin-1 is a selective RIP1 kinase inhibitor used to interrogate necroptosis, inflammation, and tissue injury. Product data report blockade of TNF-α-induced necroptosis, while peer-reviewed work connects RIP1–RIP3 signaling with inflammatory pulmonary dysfunction.

• Rocket-Like Nanomedicine Restores PDAC Stroma

  2026-08-16

  Fu and colleagues developed an acid-responsive, sequential-release nanomedicine that combines stromal remodeling with gemcitabine delivery in pancreatic ductal adenocarcinoma. By releasing halofuginone and IPR-803 before gemcitabine-loaded mesoporous silica nanoparticles, the platform restored aspects of stromal homeostasis and produced marked tumor regression in a PDAC mouse model.

• Maraviroc: CCR5 Biology from HIV to Stroke

  2026-08-15

  Maraviroc (UK-427857) is a selective CCR5 antagonist for dissecting HIV-1 entry inhibition and chemokine signaling. This article presents a compartment- and time-aware framework for connecting HIV tropism studies with emerging neuroinflammation modulation research without overstating translational evidence.

7606 records 1/508 page Next 12345 下5页 Last page